Ocugen, Inc.
Long

OCGN - good buy, WHO approval waiting

214
Good buy at this price.

Waiting for WHO approval for Covid Vaccine, it's partially approved for emergency use in India.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.